In summary, our study demonstrates that metformin effectively inhibits human bladder cancer cell proliferation and tumor growth in vitro and in vivo, possibly by inducing G0/G1 cell cycle arrest and activating AMPK/mTOR pathway. Here, MTOR is linked to urinary bladder carcinoma.